People living with HIV at higher risk of cancers caused by smoking or viruses, but not all cancers
The risk of cancer is increased twofold for people with HIV compared to individuals in the general population, Danish investigators report in the online edition of AIDS. But the increased risk was almost entirely due to higher incidence of smoking-related cancers and also malignancies caused by viral infections. ....
Low vitamin D concentrations associated with poor clinical and virological outcomes among people starting HIV therapy
Low vitamin D
concentrations are associated with an increased risk of HIV disease progression
among people starting antiretroviral therapy, investigators report in the
online edition of The Journal of
Infectious Diseases. Virological failure also had an association with low
vitamin D levels at the start of therapy, and there was evidence
suggesting a relationship with between vitamin D levels and immunological outcomes...
Launch function of the National AIDS Control Programme Phase - IV
Department of AIDS COntrol, Ministry of Health & Family Welfare, Government of India is launching NACP - Phase IV on 12 February, 2014 at the National Media Center, Raisina Road, New Delhi. Shri Ghulam Nabi Azad, Hon'ble Union Minister for Health & Family Welfare is the chief guest.
HIV Vaccine Development Required for a Durable End to AIDS
or possibly end, of HIV/AIDS pandemic could be feasible with broader global
access to lifesaving antiretroviral therapies and wider implementation.
However, a safe and at least moderately effective HIV vaccine is needed to
reach this goal more expeditiously and in a more sustainable way, according to
a new commentary from director of the National Institute of Allergy and
Bill to end HIV/AIDS discrimination introduced
A bill to protect people with HIV/AIDS against discrimination wasintroduced in Rajya Sabha on Tuesday.
The bill proposes impresonment and fine for those spreading hatred and discrimination against HIV patients.
Manipur offers job to HIV positive muscleman Pradipkumar
Odia film on HIV
TeachAIDS, a social venture of Stanford University, has come out with an animated Odia film to create HIV/AIDS awareness. It was released on December 1, World AIDS Day.
HIV on the rise in Assam
The incidence of HIV among pregnant women has increased in Assam. Bridge populations such as migrants and truckers are mainly responsible for the spread of the virus in the state.
Successful HIV drug resistance testing is possible when viral load is low
HIV drug resistance testing can perform well, even when viral load is as low as 250 copies/ml, results of two studies published in the online edition of Clinical Infectious Diseases show. In one study, genotyping was successfully performed on over 90% of samples when viral load was between 250 and 999 copies/ml. Moreover, resistance testing at low-level viraemia was shown to be of clinical benefit, with results accurately predicting the risk of an increase in viral load to above 1000 copies/ml ...
Second Batch of Scientific Writing Course from 5th - 9th December, 2011
The Knowledge Network project coordinated by Population Council is organizing a second batch of scientific writing course from 5-9 December 2011. The course designed for individuals from HIV prevention program, monitoring and advocacy partners; who will be mentored to document the programmatic learnings for wider dissemination through publication in peer reviewed journals.
The course provides a unique opportunity for program implementing professionals in the HIV sector to be trained in the process of paper writing, including reviewing the literature, conceptualizing the research problem, and analyzing and interpreting the data. Resource persons for the course include multi-disciplinary experts from various academic and program based institutions who are part of the Knowledge Network project consortium. The 1st session of the course will be conducted at St Johns Research Institute in Bangalore.
Vitamin D may improve bone health in those taking anti-HIV drug
Vitamin D may help prevent hormonal changes that can lead to bone loss among those being treated for HIV with the drug tenofovir, according to the results of a National Institutes of Health network study of adolescents with HIV…
Viral load a major factor affecting risk of sexually transmitting HIV
The level of HIV-1 in the blood of an HIV-infected partner is the single most important factor influencing risk of sexual transmission to an uninfected partner, according to a multinational study of heterosexual couples in sub-Saharan Africa. The study, published in the Journal of Infectious Diseases, calculated the risk of HIV-1 transmission per act of sexual
NACP III Dissemination Summit: Sharing good practices, innovations and impact.
The Summit was organised in New Delhi from 25-27 April 2012 to share program learnings from India and globally, and to facilitate networking across states, agencies and individuals to help India halt and reverse the HIV epidemic. Sessions included plenary talks, technical presentations and parallel oral presentations, on the following areas:
· Governance and programme management
· Targeted interventions
· Care, support and treatment
· Community mobilisation and demand generation
· Strategic information
Over 500 delegates from vulnerable communities, civil society, international and national funding organisations, State AIDS Control Societies, Technical Support Units, implementing partners, NACO, faith based organisations, and corporates participated in the summit. Six former DGs of NACO addressed the Plenary Session.
Messages from the summit
“We have an unfinished agenda...as stigma, discrimination and denial faced by HIV+ people is still very high” Additional Secretary, NACO, Aradhana Johri
“If we want zero AIDS-related deaths, India needs a massive scale up of treatment and care services. By 2015 we need at least 15 million people on treatment worldwide” UNAIDS Country Coordinator, Charles Gilks
“It is important for HIV+ persons to start ART soon to improve the quality of life.” Deputy Director General, NACO, Mohammed Shaukat
“The whole idea behind integration is not to do it in a ham-handed manner and reversing the AIDS control department’s achievements. We are not going to be insensitive to the needs of the vulnerable communities involved...We have been reminded again and again that there are a lot of centrally sponsored schemes with the same purpose on health. Some programmes of NACO are already taking place in convergence with NRHM and we will ensure the convergence is done in the right manner,” Syeda Hamid, Planning Commission
Voices from the field:
•ART centres should be made complete health centres which can provide quality counselling and information to HIV+ persons.
•NACP III has given visibility to transgenders and a face to the community; crisis response committees have been very successful; anti-trafficking committees are an important next step
•Communities are at the centre of the program; it is important to listen to the voices of the community
•NACP III has given us ART, PPCT and helped us dream big. There are still many vulnerable people, especially women, who have not been reached out to, who are blissfully unaware of their risk. They have no idea about the services or the programme.
Looking ahead: NACP III to NACP IV
•Need to scale up HIV prevention and treatment services
•Need for inputs for MSM interventions
•Need to tackle CLHIV on a higher scale
•Need to rescope the program to add transit and source area interventions for migrants
Geneva, 26 May 2011
Geneva, 26 May 2011 — At its 23rd meeting in Geneva on May 11 and 12, the Global Fund Board endorsed a Market-shaping Strategy - developed in extensive collaboration with implementers and other partners - that aims to optimize price, quality, design and sustainable supplies of health products. The strategy will initially be applied to antiretroviral medicines to treat AIDS. It aims to contribute to improved health outcomes, accelerate access to superior products and achieve significant cost savings. Under the strategy, the Global Fund will also prioritize strategic market interventions to sustain paediatric antiretroviral treatment, working with UNITAID and other partners.